Interferon-gamma and tumor necrosis factor-alpha induce synergistic cytolytic effects in ovarian cancer cell lines - Roles of the TR60 and TR80 tumornecrosis factor receptors
Er. Kost et al., Interferon-gamma and tumor necrosis factor-alpha induce synergistic cytolytic effects in ovarian cancer cell lines - Roles of the TR60 and TR80 tumornecrosis factor receptors, GYNECOL ONC, 72(3), 1999, pp. 392-401
Objective. Utilizing ovarian cancer cell lines, we examined the effect of I
FN-gamma on each type of TNF receptor. Additionally, we sought to determine
the effect of receptor modulation on TNF-alpha-mediated cytolysis.
Methods. Ovarian cancer cell lines Caov-3, A2780, and SK-OV-3 were employed
. The number of TNF receptors was determined by a TNF-alpha binding assay u
tilizing I-125-labeled TNF-alpha. Monoclonal antibodies specific for the 55
- to 60-kDa (TR60) and the 75- to 80-kDa (TR80) TNF receptors were used to
determine the relative density of each receptor type. Northern blot analyse
s were performed employing cDNA probes for the TR60 and TR80 mRNAs. To eluc
idate which receptor(s) was responsible for mediating the signal for cytoly
sis, 24-h MTT cytolytic assays were performed in the presence of receptor-s
pecific monoclonal antibodies.
Results. IFN-gamma treatment resulted in an increase in TNF receptors in th
e cell lines A2780 and Caov-3 (P < 0.001), but not SK-OV-3. Northern blot a
nalyses suggested distinct regulatory mechanisms for the two receptors. In
Caov-3 and SK-OV-3 cells a synergistic increase in TNF-alpha-mediated cytol
ysis was seen when cells were pretreated with IFN-gamma. In both cell lines
, pretreatment with IFN-gamma markedly enhanced the ability of the TR60 rec
eptor to mediate cell lysis. Conversely, under similar treatment conditions
, the TR80 receptor did not appear capable of generating a cytolytic signal
.
Conclusions. TNF receptor modulation by IFN-gamma appears to be unique to i
ndividual cell lines. The TR60 TNF receptor plays a central role in the syn
ergistic cytolytic effects of IFN-gamma and TNF-alpha. Sequential therapy w
ith IFN-gamma and TNF-alpha and specific TNF receptor activation may provid
e novel translational strategies for the use of cytokines in the treatment
of ovarian cancer. (C) 1999 Academic Press.